XM non fornisce servizi ai residenti degli Stati Uniti d'America.
A
A

ArcelorMittal


News

ArcelorMittal could boost Ukraine steel output if situation stabilises

ArcelorMittal could boost Ukraine steel output if situation stabilises By Anna Peverieri Nov 7 (Reuters) - ArcelorMittal MT.AS , the world's second-largest steelmaker, could more than double annual production by at least 3 million metric tons in war-torn Ukraine if the situation stabilises there, the steelmaker's Chief Financial Officer Genuino Christino told investors during a quarterly conference call on Thursday.
A

ArcelorMittal SA reports results for the quarter ended in September 30 - Earnings Summary

ArcelorMittal SA reports results for the quarter ended in September 30 - Earnings Summary ArcelorMittal SA MT.AS reported quarterly adjusted earnings of 37 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $1.10. The mean expectation of eight analysts for the quarter was for earnings of 55 cents per share.
A

European shares rebound on tech boost; FTSE slips on BoE inflation warning

UPDATE 2-European shares rebound on tech boost; FTSE slips on BoE inflation warning For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Germany faces snap elections Rheinmetall jumps; bets on end to Germany debt brake Italy's Banco BPM rises on offer for Anima Holding Tech and miners lead rebound STOXX 600 up 0.7% Updated at 1650 GMT By Shashwat Chauhan and Shubham Batra Nov 7 (Reuters) - European stocks regained ground on Thursday, boosted
A
R
A
B
E
F
U
G

ArcelorMittal SA <MT.N> expected to post earnings of 51 cents a share - Earnings Preview

ArcelorMittal SA expected to post earnings of 51 cents a share - Earnings Preview ArcelorMittal SA MT.N , MT is expected to report resultson November 7 for the period ending September 30 2024 The Luxembourg Luxembourg-based company is expected to report revenue of $15.254 billion, according to the mean estimate from 3 analysts, based on LSEG data. ​LSEG's mean analyst estimate for ArcelorMittal SA is for earnings of 51 cents per share.
A

France corporate earnings week ahead

DIARY-France corporate earnings week ahead Nov 1 (Reuters) - Diary of France (.FCHI) corporate earnings for the week ahead FRANCE EARNINGS Start Date Start Time(GMT) RIC Company Name Event Name 05-Nov-2024 06:30 BOUY.PA Bouygues SA Nine Months 2024 Bouygues SA Earnings Release 06-Nov-2024 BMO CAGR.PA Credit Agricole SA Q3 2024 Credit Agricole SA Earnings Release 07-Nov-2024 BMO ENGIE.PA Engie SA Q3 2024 Engie SA Earnings Release 07-Nov-2024 BMO MT.AS ArcelorMittal SA Q3 2024 ArcelorMittal SA Ear
A
B
C
L
V
P
F

ABB Partners With ArcelorMittal To Lower Environmental Impact Of Power Distribution Systems

BRIEF-ABB Partners With ArcelorMittal To Lower Environmental Impact Of Power Distribution Systems Oct 21 (Reuters) - ArcelorMittal SA MT.LU : ABB PARTNERS WITH ARCELORMITTAL TO LOWER ENVIRONMENTAL IMPACT OF POWER DISTRIBUTION SYSTEMS Source text for Workspace: ID:nNDLbS4Sbm Further company coverage: MT.LU (Gdansk Newsroom)
A
A

Ukraine's steelmakers fret as Russians advance towards key coal mine

Ukraine's steelmakers fret as Russians advance towards key coal mine Coking coal mine is vital for Ukraine's steel industry Metal exports raised almost $2 bln in January-August 2024 US, South African coking coal imports would push up costs By Pavel Polityuk KYIV, Oct 16 (Reuters) - As Russian forces grind their way towards the strategic supply hub of Pokrovsk in eastern Ukraine , they are also approaching a coking coal mine that fires the country's vital steel industry.
A

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: CVS, Frasers Group, Tetragon, Oct 11 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday: * * CVS Health CVS.N is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies in the coming months, a company spokesperson confirmed to Reuters on Friday.
A
A
B
S
U

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Updates: Nippon Steel Oct 11 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Friday: ** Nippon Steel 5401.T said it will sell its entire 50% stake in a joint-venture steel plant it has in Calvert, Alabama, with ArcelorMittal MT.LU , if the top Japanese steelmaker succeeds in a buyout bid for United States Steel X.N .
A
A
B
S
U

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Oct 11 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Friday: ** Sanofi SASY.PA has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice, the French pharmaceutical group said.
A
A
B
S
U

JPM cuts ArcelorMittal and Salzgitter as EMEA metal stocks face near-term risks

BUZZ-JPM cuts ArcelorMittal and Salzgitter as EMEA metal stocks face near-term risks ** J.P.Morgan recommends reducing EMEA metals exposure in the near-term to mitigate trade and tariff-related risks ahead of the U.S. presidential election on Nov. 5 ** It says increased protectionism if Donald Trump wins the election could benefit firms with U.S. p
A
A
J
O
S
S

ArcelorMittal, Barratt Redrow, Croda

EUROPE RESEARCH ROUNDUP-ArcelorMittal, Barratt Redrow, Croda Oct 11 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including ArcelorMittal , Barratt Redrow and Croda on Friday. HIGHLIGHTS * ArcelorMittal SA MT.AS : JP Morgan cuts to neutral from overweight * Barratt Redrow Plc BTRW.L : Citigroup cuts target price to 600p from 615p * Croda CRDA.L : JP Morgan cuts target price to 3875p from 4200p * Jet2 Plc JET2.L : Morgan Stanley raises targe
A
A
A
A
B
B
C
C
C
D
E
E
G
L
N
R
R
S
S
T
T
V
A
B

Bureau Veritas, Covestro AG, Redcare Pharmacy NV

EUROPE RESEARCH ROUNDUP-Bureau Veritas, Covestro AG, Redcare Pharmacy NV Oct 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bureau Veritas, Covestro AG and Redcare Pharmacy NV, on Wednesday. HIGHLIGHTS * British Land BLND.L : Deutsche Bank raises to buy from hold * Bureau Veritas BVI.PA : JP Morgan cuts to neutral from overweight * Covestro AG 1COV.DE : Jefferies cuts to hold from buy * Redcare Pharmacy NV RDC.DE : HSBC raises t
A
A
A
B
B
B
D
E
E
E
E
E
E
E
F
G
I
M
M
A
A
A
A
B
B
E
G
Z

ASM International, Burberry, LVMH

EUROPE RESEARCH ROUNDUP-ASM International, Burberry, LVMH Oct 1 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including ASM International, Burberry and LVMH on Tuesday. HIGHLIGHTS * ASM International ASMI.AS : Stifel cuts target price to EUR 740 from EUR 800 * Burberry Group BRBY.L : HSBC raises target price to 770p from 690p * Carlsberg CARLb.CO : Jefferies cuts target price to DKK 1,000 from DKK 1,100 * LVMH LVMH.PA : HSBC raises target p
A
A
A
A
A
B
B
G
G
G
H
H
H
H
K
K
L
L
M
P
P
R
S
V
A
B
B
I

U.S. Steel says arbitration board rules in favor of Nippon Steel's $14.9 bln buyout

UPDATE 5-U.S. Steel says arbitration board rules in favor of Nippon Steel's $14.9 bln buyout Adds Nippon Steel's comment in paragraph 11 Sept 25 (Reuters) - U.S. Steel X.N said on Wednesday an arbitration board had ruled in favour of Nippon Steel's 5401.T $14.9 billion buyout of the company, but that the United Steelworkers union (USW)disagreed with the decision.
A
U

Arcelormittal’S Xcarb Fund Invests $5 Mln In Utility Global

BRIEF-Arcelormittal’S Xcarb Fund Invests $5 Mln In Utility Global Sept 25 (Reuters) - ArcelorMittal SA MT.LU : ARCELORMITTAL’S XCARB INNOVATION FUND INVESTS IN UTILITY GLOBAL TO PROGRESS ITS GAS PROCESSING TECHNOLOGY HAS INVESTED $5 MILLION Source text for Workspace: nGNE7mNXBB Further company coverage: MT.LU (Gdansk Newsroom)
A

Arcelormittal's AM/NS Generates $5.8 Bln Cash Since Acquisition

BRIEF-Arcelormittal's AM/NS Generates $5.8 Bln Cash Since Acquisition Sept 25 (Reuters) - ArcelorMittal SA MT.LU : UPDATE ON AM/NS INDIA’S PERFORMANCE CASH GENERATION OF $5.8 BILLION SINCE ACQUISITION, WHICH HAS ENABLED $5.8 BILLION OF GROWTH INVESTMENT PROGRESS BEING MADE ON FIRST PHASE OF AM/NS INDIA’S TRANSFORMATIONAL EXPANSION PROJECT AT HA
A

U.S. Steel's proposed $14.9 billion merger with Nippon Steel

TIMELINE-U.S. Steel's proposed $14.9 billion merger with Nippon Steel Repeats Sept 5 item to fix formatting with no changes to text Sept 5 (Reuters) - The White House is set to announce that President Joe Biden will block Nippon Steel's $14.9 billion bid for the U.S. Steel X.N citing national security concerns, two sources familiar with the situation told Reuters.
A
U

US Nippon Steel rebuff would be cruel and kind

RPT-BREAKINGVIEWS-US Nippon Steel rebuff would be cruel and kind The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Antony Currie MELBOURNE, Sept 10 (Reuters Breakingviews) - So much for an M&A shortcut. It looks increasingly likely that the Biden administration is about to block Nippon Steel's 5401.T $14.9 billion agreed takeover of United States Steel X.N , Reuters reported in an exclusive on Sept.
A
U

US Nippon Steel rebuff would be cruel and kind

BREAKINGVIEWS-US Nippon Steel rebuff would be cruel and kind The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Antony Currie MELBOURNE, Sept 10 (Reuters Breakingviews) - So much for an M&A shortcut. It looks increasingly likely that the Biden administration is about to block Nippon Steel's 5401.T $14.9 billion agreed takeover of United States Steel X.N , Reuters reported in an exclusive on Sept.
A
U



Condizioni

Asset popolari

Disclaimer: le entità di XM Group forniscono servizi di sola esecuzione e accesso al nostro servizio di trading online, che permette all'individuo di visualizzare e/o utilizzare i contenuti disponibili sul sito o attraverso di esso; non ha il proposito di modificare o espandere le proprie funzioni, né le modifica o espande. L'accesso e l'utilizzo sono sempre soggetti a: (i) Termini e condizioni; (ii) Avvertenza sui rischi e (iii) Disclaimer completo. Tali contenuti sono perciò forniti a scopo puramente informativo. Nello specifico, ti preghiamo di considerare che i contenuti del nostro servizio di trading online non rappresentano un sollecito né un'offerta ad operare sui mercati finanziari. Il trading su qualsiasi mercato finanziario comporta un notevole livello di rischio per il tuo capitale.

Tutto il materiale pubblicato sul nostro servizio di trading online è unicamente a scopo educativo e informativo, e non contiene (e non dovrebbe essere considerato come contenente) consigli e raccomandazioni di carattere finanziario, di trading o fiscale, né informazioni riguardanti i nostri prezzi di trading, offerte o solleciti riguardanti transazioni che possano coinvolgere strumenti finanziari, oppure promozioni finanziarie da te non richieste.

Tutti i contenuti di terze parti, oltre ai contenuti offerti da XM, siano essi opinioni, news, ricerca, analisi, prezzi, altre informazioni o link a siti di terzi presenti su questo sito, sono forniti "così com'è", e vanno considerati come commenti generali sui mercati; per questo motivo, non possono essere visti come consigli di investimento. Dato che tutti i contenuti sono intesi come ricerche di investimento, devi considerare e accettare che non sono stati preparati né creati seguendo i requisiti normativi pensati per promuovere l'indipendenza delle ricerche di investimento; per questo motivo, questi contenuti devono essere considerati come comunicazioni di marketing in base alle leggi e normative vigenti. Assicurati di avere letto e compreso pienamente la nostra Notifica sulla ricerca di investimento non indipendente e la nostra Informativa sul rischio riguardante le informazioni sopra citate; tali documenti sono consultabili qui.

Avvertenza sul rischio: Il tuo capitale è a rischio. I prodotti con leva finanziaria possono non essere adatti a tutti. Ti chiediamo di consultare attentamente la nostra Informativa sul rischio.